AG
IGMS
Artal Group’s IGM Biosciences IGMS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-3,330,422
| Closed | -$22.9M | – | 42 |
|
|
2024
Q2 | $22.9M | Buy |
3,330,422
+250,000
| +8% | +$1.72M | 0.58% | 20 |
|
|
2024
Q1 | $29.7M | Sell |
3,080,422
-20,000
| -0.6% | -$193K | 0.76% | 19 |
|
|
2023
Q4 | $25.8M | Buy |
3,100,422
+578,178
| +23% | +$4.8M | 0.86% | 16 |
|
|
2023
Q3 | $21.1M | Hold |
2,522,244
| – | – | 0.9% | 18 |
|
|
2023
Q2 | $23.3M | Buy |
2,522,244
+12,272
| +0.5% | +$113K | 0.72% | 20 |
|
|
2023
Q1 | $34.5M | Buy |
2,509,972
+59,972
| +2% | +$824K | 2.05% | 14 |
|
|
2022
Q4 | $41.7M | Hold |
2,450,000
| – | – | 2.33% | 13 |
|
|
2022
Q3 | $55.7M | Buy |
2,450,000
+450,000
| +23% | +$10.2M | 2.38% | 12 |
|
|
2022
Q2 | $36.1M | Hold |
2,000,000
| – | – | 1.93% | 15 |
|
|
2022
Q1 | $53.5M | Buy |
2,000,000
+500,000
| +33% | +$13.4M | 2.24% | 12 |
|
|
2021
Q4 | $44M | Buy |
1,500,000
+150,000
| +11% | +$4.4M | 1.19% | 20 |
|
|
2021
Q3 | $88.8M | Buy |
1,350,000
+250,000
| +23% | +$16.4M | 1.99% | 10 |
|
|
2021
Q2 | $91.5M | Sell |
1,100,000
-25,000
| -2% | -$2.08M | 1.86% | 12 |
|
|
2021
Q1 | $86.3M | Sell |
1,125,000
-75,000
| -6% | -$5.75M | 1.52% | 14 |
|
|
2020
Q4 | $106M | Buy |
1,200,000
+511,090
| +74% | +$45.1M | 2.27% | 8 |
|
|
2020
Q3 | $50.8M | Buy |
+688,910
| New | +$50.8M | 1.23% | 15 |
|
|
2020
Q1 | – | Sell |
-150,000
| Closed | -$5.72M | – | 96 |
|
|
2019
Q4 | $5.72M | Sell |
150,000
-50,000
| -25% | -$1.91M | 0.22% | 58 |
|
|
2019
Q3 | $3.55M | Buy |
+200,000
| New | +$3.55M | 0.14% | 72 |
|